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Abstract
PDZ domain‐containing proteins (PDZ proteins) act as scaffolds for protein–protein
interactions and are crucial for a variety of signal transduction processes. However,
the role of PDZ proteins in organismal lifespan and aging remains poorly under-
stood. Here, we demonstrate that KIN‐4, a PDZ domain‐containing microtubule‐as-
sociated serine‐threonine (MAST) protein kinase, is a key longevity factor acting
through binding PTEN phosphatase in Caenorhabditis elegans. Through a targeted
genetic screen for PDZ proteins, we find that kin‐4 is required for the long lifespan
of daf‐2/insulin/IGF‐1 receptor mutants. We then show that neurons are crucial tis-
sues for the longevity‐promoting role of kin‐4. We find that the PDZ domain of
KIN‐4 binds PTEN, a key factor for the longevity of daf‐2 mutants. Moreover, the
interaction between KIN‐4 and PTEN is essential for the extended lifespan of daf‐2
mutants. As many aspects of lifespan regulation in C. elegans are evolutionarily con-
served, MAST family kinases may regulate aging and/or age‐related diseases in mam-
mals through their interaction with PTEN.
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1 | INTRODUCTION
Insulin/IGF‐1 signaling (IIS) is an evolutionarily conserved signaling
pathway that regulates organismal lifespan. In Caenorhabditis elegans,
mutations in the insulin/IGF‐1 receptor, daf‐2, substantially increase
lifespan (Kenyon, 2010). Longevity conferred by daf‐2 mutations
requires various proteins, including DAF‐18/PTEN and transcription
factors such as DAF‐16/FOXO, heat‐shock factor‐1 (HSF‐1), and
SKN‐1/NRF2. The DAF‐18/PTEN protein dephosphorylates phos-
phatidylinositol‐3,4,5‐trisphosphate (PI(3,4,5)P3) to phosphatidylinosi-
tol‐4,5‐bisphosphate (PI(4,5)P2) (Solari et al., 2005). This leads to the
inactivation of AKT kinases and subsequent activation of longevity‐
promoting DAF‐16/FOXO (Reviewed in Altintas, Park, & Lee, 2016;
Kenyon, 2010).
The PDZ (PSD‐95/Dlg‐1/ZO‐1) domain‐containing proteins (here-
after referred to as PDZ proteins) act as scaffolds for protein–protein
interactions and mediate various cellular signaling processes
(Reviewed in Kim & Sheng, 2004). PDZ domains are composed of
six β‐sheets and two α‐helices and comprise ~90 amino acids. PDZ
proteins typically bind the PDZ‐binding motifs that are located at
the C‐terminal regions of the partner proteins. Roles of various PDZ
proteins in cellular processes, such as signal transduction in neurons,
are relatively well established; however, their function in aging and
lifespan regulation is underexplored.
KIN‐4 is the sole homolog of the human microtubule‐associated
serine/threonine kinase 1/2/3 (MAST1/2/3) in C. elegans, which con-
tains a PDZ domain and a protein kinase domain (Manning, 2005).
Human MAST family kinases are implicated in the inhibition of neu-
rite outgrowth and regeneration in cultured cells (Loh, Francescut,
Lingor, Bahr, & Nicotera, 2008). The sole Drosophila homolog of the
human MAST kinase, Drop out, regulates dynein‐dependent trans-
port during embryonic development (Hain et al., 2014). MAST
kinases also bind to various proteins, including microtubules (Walden
& Cowan, 1993), β2‐syntrophin (Lumeng et al., 1999), TNF receptor‐
associated factor 6 (TRAF6) (Xiong, Li, Chen, Zhao, & Unkeless,
2004), cAMP‐regulated phospho‐protein (ARPP‐16) (Andrade et al.,
2017), and PTEN (Valiente et al., 2005). Despite these findings, the
role of MAST kinases in organismal aging remains unknown.
In the current study, we investigated the role of KIN‐4 in lifespan
regulation conferred by reduced IIS in C. elegans. We used RNA
interference (RNAi) to screen for genes encoding PDZ proteins that
affected the lifespan of C. elegans. Our results showed that KIN‐4
was required for the long lifespan of daf‐2 mutants. kin‐4 was partly
required for dauer formation and oxidative stress resistance in daf‐2
mutants. Moreover, kin‐4 in neurons was crucial for the extension of
lifespan by daf‐2 mutations. Through a large‐scale yeast two‐hybrid
screen and subsequent protein–protein binding assays, we found
that DAF‐18/PTEN bound to the PDZ domain of KIN‐4 through its
C‐terminus. More importantly, the interaction between KIN‐4 and
DAF‐18/PTEN was required to extend the lifespan of daf‐2 mutants.
Our findings suggest that MAST family kinases exert physiological
effects on lifespan regulation via modulating IIS pathways through
direct interaction with PTEN.
2 | RESULTS
2.1 | KIN‐4 is required for longevity conferred by
reduced IIS
We aimed at identifying PDZ proteins that contribute to C. elegans
longevity. We first identified 80 PDZ protein‐encoding genes by
using Pfam and WormBase and by performing literature searches
(Supporting information Table S1). We then examined the effect of
each of the commercially available RNAi clones, targeting 49 candi-
date genes, on the lifespan of control worms and daf‐2/insulin/IGF‐1
receptor mutants (Figure 1a and Supporting information Table S2);
we used daf‐2 mutants that display a prominent longevity phenotype
(Kenyon, 2010), as the effect of RNAi on the lifespan of these
mutants would be more pronounced than on the wild‐type (Seo
et al., 2015). Many PDZ proteins play roles in neurons (Reviewed in
E. Kim & Sheng, 2004); because C. elegans neurons are refractory to
RNAi (Timmons, Court, & Fire, 2001), we used rrf‐3 mutant animals
that display enhanced sensitivity to RNAi (Asikainen, Vartiainen,
Lakso, Nass, & Wong, 2005) (Figure 1a; Supporting information
Table S2). We found that RNAi targeting kin‐4, which encodes a
MAST family kinase (Manning, 2005), or gipc‐1 and gipc‐2, which
encode GAIP‐interacting protein C proteins (Vartiainen, Pehkonen,
Lakso, Nass, & Wong, 2006), had greater lifespan‐shortening effects
on daf‐2 mutants than on control animals (Figure 1a–c). We then
determined the effects of genetic inhibition of kin‐4 or gipc‐1/‐2 on
daf‐2(–) longevity using available loss of function mutants. Two inde-
pendent kin‐4 deletion mutations substantially suppressed the long
lifespan of daf‐2 mutants (Figure 2a, b; Supporting information Fig-
ure S1a, b), whereas gipc‐1; gipc‐2 double mutations did not (Sup-
porting information Figure S1c). These data suggest that kin‐4
contributes to longevity caused by daf‐2 mutations.
Next, we determined the effect of kin‐4 mutation on longevity
conferred by other gene mutations. The kin‐4 mutation fully sup-
pressed the longevity of the sensory neuron‐defective osm‐5
mutants (Figure 2c), in which IIS is decreased (Apfeld & Kenyon,
1999), but did not affect the longevity of dietary restriction‐mimetic
eat‐2 mutants (Figure 2d). These data are consistent with the possi-
bility that KIN‐4 functions in IIS for C. elegans longevity.
2.2 | kin‐4 is partly required for enhanced dauer
formation and oxidative stress resistance caused by
daf‐2 mutations
We sought to determine the role of KIN‐4 in other daf‐2(−)‐mediated
physiological processes, including development and stress resistance.
kin‐4 mutations significantly reduced the formation of daf‐2 mutation‐
induced dauer, a hibernation‐like alternative larva (Hu, 2007), at
22.5°C but not at 25°C (Figure 2e; Supporting information Figure S2a).
Additionally, the kin‐4 mutation partially suppressed the oxidative
stress resistance of daf‐2 mutants (Figure 2f) but further increased the
enhanced pathogen resistance conferred by daf‐2 mutations (Fig-
ure S2b). The thermotolerance of wild‐type and daf‐2 mutant worms
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F IGURE 1 KIN‐4 is a PDZ protein that is required for the longevity of daf‐2/insulin/IGF‐1 receptor mutants. (a) A plot of percent changes
in mean lifespan of rrf‐3(pk1426) [rrf‐3(−)] and rrf‐3(pk1426); daf‐2(e1370) [rrf‐3(−); daf‐2(−)] mutants upon knocking down each candidate PDZ
protein‐encoding gene. Orange circles indicate the lifespan results after knocking down each targeted gene. Blue circles indicate the effects of
kin‐4 RNAi and gipc‐1/‐2 RNAi on lifespan. A gray circle indicates the lifespan decrease by daf‐16 RNAi that was used as a positive control.
Error bars represent standard error of mean (SEM) of two independent lifespan experiments for each RNAi clone. (b, c) Knock‐down of kin‐4 (b)
or gipc‐1/‐2 (c) had a larger lifespan‐decreasing effect on rrf‐3(−); daf‐2(−) mutants than on rrf‐3(−) animals. See Supporting information
Table S2 for statistics and additional repeats
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F IGURE 2 kin‐4 is required for various phenotypes conferred by reduced insulin/IGF‐1 signaling. (a, b) kin‐4(tm1049) [kin‐4(−)] (a) and kin‐4
(nj170) (b) mutation decreased the long lifespan of daf‐2(e1370) [daf‐2(−)] mutants without FUdR treatment. This lifespan‐shortening effect of
kin‐4(−) mutation was confirmed by using daf‐2(RNAi) worms with or without FUdR treatment (Supporting information Figure S1d, e). (c) kin‐4
(−) fully suppressed the lifespan extension by osm‐5(p813) [osm‐5(−)]. (d) kin‐4(−) mutation did not affect the lifespan increase by eat‐2(ad1116)
[eat‐2(−)]. See Supporting information Table S3 for experimental repeats and statistics. (e) kin‐4(−) mutation reduced the dauer formation of
daf‐2(−) mutants at 22.5°C (10 independent experiments with ≥33 worms for each trial. Error bars represent SEM. two‐tailed Student's t test.
∗ p < 0.05). See Supporting information Table S4 for statistical analysis. (f) The enhanced oxidative stress resistance of daf‐2(−) mutants was
partially suppressed by kin‐4(−) mutation upon treating with 7.5 mM of tert‐Butyl hydroperoxide (t‐BOOH). See Supporting information
Table S5 for statistics and experimental repeats
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was not significantly affected by the kin‐4 mutation (Supporting infor-
mation Figure S2c). Thus, KIN‐4 appears to play roles in various IIS‐
mediated physiological processes in a context‐dependent manner.
2.3 | Neuronal kin‐4 contributes to longevity
conferred by daf‐2 mutation
KIN‐4 contains a protein kinase domain and a PDZ domain (Figure 3a)
and is highly conserved in multiple species (Supporting information Fig-
ure S3a, b). To determine the expression pattern of KIN‐4 and the effect
of kin‐4 overexpression, we characterized transgenic animals expressing
KIN‐4 tagged with the green fluorescent protein (GFP). We found that
fusions of both the genomic kin‐4 and kin‐4 isoform a (kin‐4a) with GFP
(kin‐4::gfp and kin‐4a::gfp, respectively) were expressed mainly in neu-
rons and also in intestinal cells (Figure 3b, c; Supporting information Fig-
ure S4a). These results were confirmed using transgenic animals
expressing kin‐4 promoter‐driven GFP (kin‐4p::gfp) (Supporting informa-
tion Figure S4b). The kin‐4a::gfp transgene largely restored longevity in
daf‐2; kin‐4 double mutants (Figure 3d) but did not affect the lifespan of
wild‐type animals (Figure 3e; Supporting information Figure S4c).
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F IGURE 3 Neurons are crucial tissues for lifespan regulation by KIN‐4. (a) KIN‐4a is predicted to have 4 domains; DUF1908 whose
function is not known, pre‐PK that is mainly found in MAST family kinases, protein kinase, and PDZ domains. The deleted part by kin‐4
(tm1049) mutation is marked with a black solid line. (b, c) kin‐4::gfp transgene‐encoded protein (KIN‐4::GFP) was mainly expressed in head and
tail (c) neurons (arrowheads) and dimly in the intestine (arrow). Scale bar indicates 50 μm. (d) KIN‐4a::GFP increased the shortened lifespan of
daf‐2(e1370); kin‐4(tm1049) [daf‐2(−); kin‐4(−)] mutants. (e) kin‐4 transgenic worms did not display longevity. We also found that daf‐2 RNAi
did not alter KIN‐4::GFP levels (Supporting information Figure S4d). See Supporting information Table S3 for experimental repeats and
statistics. (f) Tissue‐specific promoter‐driven kin‐4a expression [daf‐2(−); kin‐4(−); kin‐4a::gfp] in neurons (daf‐2(e1370); kin‐4(tm1049); rgef‐1p::
kin‐4a::gfp) prolonged the shortened lifespan of daf‐2(e1370); kin‐4(tm1049) [daf‐2(−); kin‐4(−)] mutants. (g) Transgenic expression of kin‐4a in
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daf‐2(−) mutants was decreased by neuron‐specific (sid‐1(pk3321); uIs69[myo‐2p::mCherry; unc‐119p::sid‐1]) kin‐4 RNAi treatment. (i) Knock‐
down of kin‐4 in the intestine (rde‐1(ne213); kbIs7[nhx‐2p::rde‐1; rol‐6(su1006)]) significantly suppressed the long lifespan of daf‐2 mutants. See
Supporting information Table S3 for experimental repeats and statistics
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To further test the tissue‐specific roles of KIN‐4 in longevity, we
performed lifespan assays with both tissue‐specific kin‐4 transgene
and RNAi techniques. Neuronal expression of kin‐4 (Figure S5a) res-
cued the shortened lifespan of daf‐2; kin‐4 double mutants (Fig-
ure 3f). In contrast, kin‐4 expression in the intestine or hypodermis
(Figure S5b, c) had no effect on the lifespan of daf‐2; kin‐4 mutants
(Figure 3g; Supporting information Figure S5d). We then performed
converse tissue‐specific kin‐4 RNAi knock‐down experiments. We
first confirmed that treatment with kin‐4 RNAi decreased kin‐4
mRNA levels (Supporting information Figure S5e). Neuron‐specific
knock‐down of kin‐4 shortened the lifespan of daf‐2 mutants but
had minimal effects on the lifespan of control animals (Figure 3h). In
addition, kin‐4 knock‐down in the intestine significantly suppressed
the longevity of daf‐2 mutants (Figure 3i); however, kin‐4 RNAi in
other tissues had no effect on longevity (Supporting information Fig-
ure S5f–j). Altogether, these data indicate that KIN‐4 expression in
neurons is necessary for long lifespan and sufficient to restore the
longevity in daf‐2 mutants.
2.4 | KIN‐4 does not seem to affect canonical DAF‐
16/FOXO transcription factor activity in daf‐2
mutants
DAF‐16/FOXO is an essential transcription factor that mediates the
longevity of daf‐2 mutants (Reviewed in Altintas et al., 2016;
Kenyon, 2010). We therefore asked whether kin‐4 influenced the
activity of DAF‐16/FOXO for increasing lifespan in daf‐2 mutants.
We found that kin‐4 mutations did not affect the nuclear localization
of DAF‐16/FOXO in daf‐2 mutants (Supporting information Fig-
ure S6a, b). Similarly, kin‐4 mutations in daf‐2 mutants did not reduce
the mRNA levels of three selected DAF‐16 targets, sod‐3, dod‐11,
and mtl‐1 (Supporting information Figure S6c–e). We confirmed
these results using sod‐3p::gfp transgenic animals (Supporting infor-
mation Figure S6f). These data suggest that kin‐4 influences reduced
IIS‐mediated longevity by acting through factors other than DAF‐16/
FOXO.
2.5 | Identification of KIN‐4‐interacting proteins
that contribute to the longevity of daf‐2 mutants
Because KIN‐4 has a PDZ domain, we sought to identify proteins
that bound to the PDZ domain, as these may contribute to longevity
together with KIN‐4. We conducted an exhaustive yeast two‐hybrid
screen using the PDZ domain of KIN‐4 as bait against C. elegans
cDNA library and identified 41 prey proteins (Supporting information
Figure S7). Of these, 23 proteins contained putative PDZ‐binding
motifs at their C‐termini (Supporting information Table S6). To deter-
mine whether any of these 23 proteins were required for the long-
evity of daf‐2 mutants, we performed an RNAi lifespan screen
targeting 21 genes (Figure 4a; Supporting information Table S7).
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F IGURE 4 DAF‐18/PTEN binds KIN‐4 to affect the longevity of daf‐2 mutants. (a) Percent lifespan changes by knocking down each of 21
genes that encode proteins that bound the PDZ domain of KIN‐4 in rrf‐3(pk1426) [rrf‐3(−)] and rrf‐3(pk1426); daf‐2(e1370) [rrf‐3(−); daf‐2(−)]
mutants. Orange circles indicate the effects of RNAi clones on lifespan. Blue circles indicate RNAi clones that displayed bigger lifespan‐
decreasing effects on rrf‐3(−); daf‐2(−) mutants than on rrf‐3(−) worms. A red circle indicates an RNAi clone that further increased the long
lifespan of rrf‐3(−); daf‐2(−) mutants. Error bars represent SEM of mean survival times from two or three independent RNAi lifespan
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rrf‐3(−) animals. (e) rps‐0 RNAi treatment further increased the long lifespan induced by daf‐2(−) mutation in an rrf‐3(−) background. See
Supporting information Table S7 for experimental repeats and statistical analyses
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Knock‐down of daf‐18/PTEN, mel‐11/myosin‐associated phosphatase
regulatory subunit, or mig‐6/papilin and lacunin had greater lifespan‐
shortening effects on daf‐2 mutants than on control animals (Fig-
ure 4b–d). In addition, RNAi targeting rps‐0, which encodes a small
ribosomal subunit SA protein, further extended the lifespan of daf‐2
mutants (Figure 4e). Among these candidates, the expression pattern
of MEL‐11 (Wissmann, Ingles, & Mains, 1999) or MIG‐6 (Jafari et al.,
2010; Kawano et al., 2009) is not predicted to overlap with that of
KIN‐4, and the effect of rps‐0 RNAi on lifespan was opposite of that
caused by the genetic inhibition of kin‐4. Taking these results into
consideration, we further analyzed the functional role of DAF‐18/
PTEN in the longevity regulation by KIN‐4.
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depicts the domain regions in KIN‐4. (h) Illustration of wild‐type and deletion mutant DAF‐18 that were used for GST pull‐down assays. Wild‐
type DAF‐18 [WT] has the intact DAF‐18 C‐terminal PDZ‐binding motif. DAF‐18 deletion mutant proteins, [Δ4C] and [Δ12C], do not contain
the last 4 and 12 amino acids from its C‐terminal ends, respectively. (i) GST pull‐down assays using wild‐type or mutant FLAG‐tagged full‐
length DAF‐18 [FLAG‐DAF‐18] with GST‐fused KIN‐4 PDZ domain [GST‐KIN‐4 PDZ] proteins. GST KIN‐4 PDZ strongly bound to FLAG-DAF‐
18 WT [WT] but weakly to FLAG‐DAF‐18 Δ4C [Δ4C] and FLAG‐DAF‐18 Δ12C [Δ12C]
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2.6 | DAF‐18/PTEN binds to KIN‐4
DAF‐18/PTEN contributes to the longevity of daf‐2 mutants by act-
ing as a downstream phosphoinositide phosphatase (Reviewed in
Altintas et al., 2016; Kenyon, 2010). Human PTEN interacts with
MAST2, a homolog of KIN‐4, in cultured cells (Valiente et al., 2005),
although the physiological role of this interaction has not been
investigated. We determined the subcellular localization of KIN‐4
and DAF‐18 in vivo and found that KIN‐4::GFP and mCherry‐tagged
DAF‐18 (mCherry::DAF‐18) co‐localized to the cytoplasm of neurons
(Figures 5a–c). Next, we performed in silico analysis of the PDZ
domain of KIN‐4 (Figure 5d), based on the crystal structure of the
PDZ domain of human MAST2 (Terrien et al., 2012). Our structural
modeling indicated potential interaction between the PDZ domain of
KIN‐4 and the C‐terminal region of DAF‐18/PTEN (Figure 5e).
Specifically, the C‐terminal PDZ‐binding motif of DAF‐18/PTEN was
located in the groove of the PDZ domain of KIN‐4 (Figure 5e). Addi-
tionally, key residues in the human MAST2 that interact with human
PTEN, including isoleucine (I1121), valine (V1123), methionine
(M1136), and leucine (L1191) (Terrien et al., 2012), were highly con-
served as V1186, V1188, I1202, and L1257, respectively, in KIN‐4
(Figure 5e). Moreover, amino acid residues including tyrosine (T401)
and valine (V403) in the PDZ‐binding motif and phenylalanine (F392)
at the C‐terminal region of human PTEN, which are important for
the interaction with human MAST2 (Terrien et al., 2012), were gen-
erally conserved in C. elegans DAF‐18/PTEN as I960, L962, and
F951, respectively (Figure 5e; Supporting information Figure S8).
We then experimentally tested the importance of the C‐terminal
region of DAF‐18/PTEN for the interaction between KIN‐4 and DAF‐
18/PTEN. Co‐immunoprecipitation assays using HEK293T cells con-
firmed that KIN‐4 bound to DAF‐18/PTEN (Figure 5f). Using glu-
tathione S‐transferse (GST) pull‐down assays, we showed that the
PDZ domain‐containing C‐terminal (C) region of KIN‐4 interacted with
DAF‐18/PTEN, whereas the N‐terminal (N) or middle (Mid) region of
KIN‐4 did not (Figure 5g). We then asked which regions and the resi-
dues of DAF‐18/PTEN were important for its interaction with KIN‐4
by generating FLAG‐tagged wild‐type and mutant DAF‐18/PTEN pro-
teins and performing GST pull‐down assays using a GST‐fused KIN‐4
PDZ domain (Figure 5h–i). We found that 4‐amino acid and 12‐amino
acid deletions at the C‐terminus (Δ4C and Δ12C, respectively) sub-
stantially decreased the interaction between the PDZ domain of KIN‐
4 and DAF‐18/PTEN (Figure 5i). These data indicate that the PDZ
domain of KIN‐4 binds to the C‐terminal end of DAF‐18/PTEN.
2.7 | Interaction between KIN‐4 and DAF‐18/PTEN
is crucial for the longevity of daf‐2 mutants
Next, we examined whether the interaction between KIN‐4 and
DAF‐18/PTEN contributed to reduced IIS‐mediated longevity. We
generated transgenic animals expressing mutant forms of DAF‐18/
PTEN proteins carrying Δ4C and Δ12C fused with mCherry (daf‐18
Δ4C and daf‐18 Δ12C, respectively) and those expressing mCherry‐
tagged wild‐type (WT) DAF‐18 (daf‐18 WT) as a control. Expression
of all these three mCherry‐fused DAF‐18/PTEN proteins was
detected, and their subcellular localization was enriched at the
plasma membrane (Figure 6a). We found that daf‐18 WT fully
restored the longevity of daf‐2; daf‐18 double mutants (Figure 6b).
In contrast, daf‐18 Δ4C or daf‐18 Δ12C only partially restored long-
evity in daf‐2; daf‐18 double mutants (Figure 6c, d). These data sug-
gest that the C‐terminal end of DAF‐18/PTEN, which mediates the
physical interaction with KIN‐4, is required for the full longevity of
daf‐2 mutants. We also found that kin‐4 mutation further shortened
the lifespan of daf‐18 Δ12C‐expressing daf‐2; daf‐18 mutants (Sup-
porting information Figure S9). These data indicate that KIN‐4 pro-
motes longevity in daf‐2 mutants via other factors in addition to
DAF‐18, and/or that DAF‐18 C‐terminal region promotes daf-2(-)
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F IGURE 6 The interaction between
KIN‐4 and DAF‐18 is crucial for longevity
caused by IIS reduction. (a) Expression
pattern of wild‐type [daf‐18 WT], the last
four amino acid deletion mutant DAF‐18
transgene [daf‐18 Δ4C] and the last 12
amino acid deletion mutant daf‐18
transgene [daf‐18 Δ12C], fused with
mCherry in the posterior intestine cells. (b)
daf‐18 WT fully suppressed lifespan
reduction by daf‐18(nr2037) [daf‐18(−)]
mutation in daf‐2(e1370) [daf‐2(−)] animals.
(c) Two independent lines of daf‐18 Δ4C
only partially increased the shortened
lifespan of daf‐2(−); daf‐18(−) mutants. (d)
daf‐18 Δ12C had small lifespan‐increasing
effects on the shortened lifespan of daf‐2
(−); daf‐18(−) animals. See Supporting
information Table S3 for statistics and
additional repeats
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longevity via KIN‐4‐independent targets. Altogether, our data sug-
gest that KIN‐4 contributes to longevity in daf‐2 mutants partly
through binding to DAF‐18/PTEN at the C‐terminus.
3 | DISCUSSION
3.1 | C. elegans MAST family kinase KIN‐4
promotes longevity via binding DAF‐18/PTEN
PDZ proteins function as scaffolds that organize proteins for trans-
ducing various intracellular signals. However, the role of PDZ proteins
in IIS, an important evolutionarily conserved lifespan‐regulatory sig-
naling, has been poorly understood. In this study, we showed that
KIN‐4/MAST kinase was a lifespan‐regulatory PDZ protein acting
through DAF‐18/PTEN. KIN‐4, mainly in neurons, influenced the long-
evity conferred by reduced IIS. We also identified DAF‐18/PTEN as a
key interacting protein of KIN‐4. The interaction between KIN‐4 and
DAF‐18/PTEN was important for the lifespan regulation by IIS. Our
study suggests that KIN‐4/MAST family kinase is a novel longevity‐
promoting protein that acts in IIS via binding DAF‐18/PTEN protein.
3.2 | KIN‐4 affects lifespan differently from
previously reported PDZ proteins, MICS‐1 and MPZ‐1
Previous studies have reported lifespan‐influencing PDZ proteins,
including MICS‐1/synaptojanin 2 binding protein (SYNJ2BP) and multi‐
PDZ domain scaffold protein (MPZ‐1), in C. elegans (Hoffmann et al.,
2012; Palmitessa & Benovic, 2010). The genetic inhibition of mics‐1
promotes longevity (Hoffmann et al., 2012), and mpz‐1 knock‐down
increases lifespan, perhaps by activating DAF‐18/PTEN (Palmitessa &
Benovic, 2010). Both mics‐1 and mpz‐1 genes were included in our
RNAi lifespan screen (Supporting information Table S2); however,
RNAi targeting of mics‐1 or mpz‐1 had small or no effect on lifespan in
wild‐type or daf‐2 mutant animals (Figure 1a; Supporting information
Table S2). In contrast, kin‐4 mutation or RNAi substantially suppressed
the extended lifespan of daf‐2 mutants. This difference may have
arisen from different genetic backgrounds and/or experimental condi-
tions; for example, mics‐1 RNAi lifespan assay was performed at 25°C
(Hoffmann et al., 2012), and mpz‐1 RNAi was applied for two genera-
tions to wild‐type worms (Palmitessa & Benovic, 2010). Here, we per-
formed lifespan assays using RNAi‐sensitive rrf‐3 mutants treated with
each of these RNAi clones only during adulthood at 20°C. Despite the
difference, previous reports do not conflict with our data showing that
KIN‐4 is required for the extended lifespan of C. elegans conferred by
reduced IIS. We speculate that KIN‐4 contributes to IIS‐mediated long-
evity in a manner distinct from MPZ‐1 or MICS‐1.
3.3 | kin‐4 mutation appears to elicit a
compensatory activation of DAF‐16/FOXO in daf‐2
mutants
Although a major protein acting downstream of DAF‐18/PTEN
lipid phosphatase is DAF‐16/FOXO, we did not find evidence
supporting the possibility that KIN‐4 acts with DAF‐18/PTEN for
increasing DAF‐16/FOXO activity. In contrast, DAF‐16/FOXO activ-
ity in daf‐2 mutant animals appears to be further increased by
kin‐4(−) mutations (Supporting information Figure S6). We specu-
late that kin‐4(−) mutations decrease lifespan in daf‐2 mutants via
DAF‐18/PTEN while acting through factors other than DAF‐16/
FOXO and that this in turn enhances DAF‐16/FOXO activity as a
compensatory response. Genetic inhibition of several DAF‐16/
FOXO‐independent factors that contribute to reduced IIS‐mediated
longevity has been shown to elicit compensatory activation of
DAF‐16/FOXO. For example, we previously reported that muta-
tions in smg‐2/UPF1, a key factor for nonsense‐mediated mRNA
decay, decrease the longevity of daf‐2 mutants, while further
increasing DAF‐16/FOXO activity (Son et al., 2017). In addition,
PQM‐1, paraquat (methyl viologen)‐responsive transcription factor,
is required for longevity in daf‐2 mutants, but genetic inhibition of
pqm‐1 increases the nuclear localization of DAF‐16 (Tepper et al.,
2013). It will be interesting to determine whether KIN‐4 and
DAF‐18/PTEN act with DAF‐16/FOXO‐independent longevity fac-
tors for contributing to long lifespan in C. elegans with reduced
IIS.
3.4 | KIN‐4 may increase DAF‐18/PTEN activity via
phosphorylation
Post‐translational modifications of PTEN, including phosphorylation,
are important for its regulation (Fragoso & Barata, 2015). In many
cases, phosphorylation at the C‐terminal region of PTEN leads to its
conformational change that inhibits the lipid phosphatase activity of
PTEN (Fragoso & Barata, 2015). On the other hand, Rak tyrosine
kinase and polo‐like kinase 3 (Plk3) activate PTEN by phosphorylat-
ing the C2 domain and C‐terminal part of PTEN, respectively (Xu,
Yao, Jiang, Lu, & Dai, 2010; Yim et al., 2009). In addition, RhoA‐asso-
ciated kinase (ROCK) phosphorylates PTEN and increases its activity
(Li et al., 2005). Mammalian MAST2 also phosphorylates PTEN
in vitro (Valiente et al., 2005), although its effect on the activity of
PTEN remains unexplored. Given the similar lifespan phenotypes
caused by mutations in daf‐18/PTEN and kin‐4, we speculate that C.
elegans KIN‐4 may increase the activity of DAF‐18/PTEN through
binding and phosphorylation.
3.5 | KIN‐4 contributes to longevity possibly
through altering the protein phosphatase activity of
DAF‐18/PTEN
Taking into consideration that DAF‐18/PTEN has dual phos-
phatase activity for both proteins and lipids (Fragoso & Barata,
2015), it seems likely that the binding of KIN‐4 may affect the
phosphatase activity of DAF‐18/PTEN for as yet unidentified
substrate proteins. In mammals, substrate proteins of PTEN phos-
phatase include protein kinase B/Akt and cyclic AMP response
element‐binding protein (CREB; Gu et al., 2011; Phadngam et al.,
2016). Therefore, homologs of these proteins may mediate the
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effects of the interaction between KIN‐4 and DAF‐18/PTEN on
the longevity of C. elegans. One limitation regarding this scenario
is that tyrosine 138, which is essential for the protein phos-
phatase activity of PTEN in mammals (Davidson et al., 2010), is
replaced by leucine in C. elegans DAF‐18/PTEN. Nevertheless, C.
elegans DAF‐18/PTEN can act as a protein phosphatase for VAB‐
1/ephrin receptor (Brisbin et al., 2009). Therefore, it will be
important to identify and functionally characterize protein sub-
strates of DAF‐18/PTEN in C. elegans in future research, with
respect to the role of KIN‐4 in protein–protein interaction and
longevity.
3.6 | KIN‐4 appears to contribute to longevity in
daf‐2 mutants by acting with other factors as well as
with DAF‐18/PTEN
In this paper, we showed that physical interaction between KIN‐4
and DAF‐18/PTEN is required for full longevity of daf‐2 mutants.
However, KIN‐4 also seems to contribute to reduced IIS‐mediated
longevity through additional factors. The mammalian MAST kinases
bind various proteins, including microtubules (Walden & Cowan,
1993), β2‐syntrophin (Lumeng et al., 1999), TRAF6 (Xiong et al.,
2004), and ARPP‐16 (Andrade et al., 2017). We also identified vari-
ous factors that bound the PDZ domain of C. elegans KIN‐4 through
a yeast two‐hybrid screen (Supporting information Table S6). Thus,
KIN‐4 binding to some of these proteins may contribute to longevity
in daf‐2 mutants. In addition, MAST2 and MAST3 kinases phospho-
rylate Na+/H+ exchanger 3 (NHE3; Wang et al., 2006) and ARPP‐16
(Andrade et al., 2017), respectively, and therefore, phosphorylation
of C. elegans homologs of these proteins by KIN‐4 may affect
reduced IIS‐mediated longevity. It will be important to test these
possibilities by performing biochemical and molecular genetic experi-
ments in future studies.
3.7 | Interaction between MAST kinases and PTEN
may play important roles in mammalian physiology
Several lines of evidence indicate that MAST kinases are crucial for
the physiology of cancer cells (Eissmann et al., 2013; Robinson et al.,
2011; Tomoshige et al., 2015). In some breast cancer cells, MAST1
and MAST2 are fused with other proteins through recurrent gene
rearrangements; these fusion proteins act as putative tumorigenic
drivers (Robinson et al., 2011). A pedigree study reported that
MAST1 variants are associated with lung cancer (Tomoshige et al.,
2015). Furthermore, MAST2 influences glioblastoma tumor growth,
potentially as an apoptosis suppressor (Eissmann et al., 2013). In this
study, we characterized the physiological role of the physical interac-
tion between KIN‐4 and DAF‐18/PTEN in C. elegans. Considering
evolutionarily conserved amino acid sequences of these proteins, our
study may provide insights into the role of MAST kinases and PTEN
in tumorigenesis and aging, thus contributing toward the develop-
ment of therapeutic strategies for anti‐cancer and anti‐aging
medicine.
4 | EXPERIMENTAL PROCEDURES
4.1 | Strains
All strains used in this study are described in the Supporting Infor-
mation.
4.2 | Identification of PDZ proteins
Identification of potential C. elegans PDZ proteins was performed by
using combination of bioinformatic methods similarly to a previous
paper (Seo et al., 2015). See the supporting information for details.
4.3 | Lifespan assays
Lifespan assays were conducted at 20°C as previously described,
with some modifications (Lee et al., 2015). See the Supporting Infor-
mation for details.
4.4 | Dauer formation
Dauer assays were performed as previously described, with some
modifications (Gaglia et al., 2012). Gravid adult worms were placed
on OP50‐seeded NGM plates and were allowed to lay eggs for 3 hr
at 22.5°C and 25°C. The number of dauers and total worms was
counted when non‐dauer worms reached L4 or young adult stage.
Error bars indicate SEM, and statistics were calculated by using Stu-
dent's t test.
4.5 | Stress resistance assays
Stress resistance assays were performed by following a previous
report with some modifications (Seo et al., 2015). See the Supporting
Information for details.
4.6 | Generation of transgenic worms
Transgenic worms were generated as previously described, with
some modification (Artan et al., 2016). See the Supporting Informa-
tion for details.
4.7 | Generation of mutant strain using CRISPR
To generate kin‐4(nj170), the homologous recombination was per-
formed essentially by following a previous report (Dickinson, Ward,
Reiner, & Goldstein, 2013). First, the kin‐4 locus was replaced by a
repair template (pSN588) that carries the loxP‐unc‐119(+)‐loxP
sequence flanked by the left and right arms corresponding to the 1st
intron and the 3′ UTR genomic sequence of kin‐4, respectively. This
repair template was injected into unc‐119(ed3) animals with peft‐3::
Cas9 and an sgRNA plasmid (pSN598) to generate a double‐stranded
break at the kin‐4 locus. Progeny were screened for animals in which
the kin‐4 locus was replaced by the repair template. The loxP‐unc‐
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119(+)‐loxP cassette was subsequently removed by injecting peft‐3::
Cre plasmid (pDD104). The animals in which the unc‐119(+) gene
was excised were isolated and were confirmed by DNA sequence
analysis. The resulting strain carries a 17 kb deletion in the kin‐4
locus and removes the sequence between 24,629 of the cosmid
F22B3 and 11,644 of the cosmid C10C6. The unc‐119(ed3) mutation
was then crossed out to obtain IK2019.
4.8 | Yeast two‐hybrid screen
Yeast two‐hybrid screen was performed by Panbionet (http://panb
ionet.com) following a previous report (Kim et al., 2008). See the
Supporting information for details.
4.9 | Prediction of protein domains, structure
modeling and sequence alignment, and generation of
the phylogenic tree
Prediction of protein domains, structure modeling and sequence
alignment, and generation of the phylogenic tree were performed
similarly to a previous paper (Hwang et al., 2015), with modifications.
See the Supporting Information for details.
4.10 | Co‐immunoprecipitation and immunoblotting
Co‐immunoprecipitation and immunoblotting were performed follow-
ing a previous report (Seo et al., 2015) with some modifications. See
the Supporting Information for details.
4.11 | GST pull‐down assay
GST pull‐down assays were performed following methods described
in a previous report (Dev, Nishimune, Henley, & Nakanishi, 1999)
with some modifications. See the Supporting Information for details.
4.12 | Microscopy
Microscopy experiments were executed as previously described with
some modifications (Son et al., 2017). See the Supporting Informa-
tion for details.
4.13 | Quantitative RT–PCR analysis
Quantitative RT–PCR experiments were performed as previously
described with some modifications (Son et al., 2017). See the Sup-
porting information for details.
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